Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Interim Body Weight Results From Lexaria's Diabetes Animal Study; Says DehydraTech Appears To Work With A Second GLP-1 Drug Liraglutide; DehydraTech-CBD Is Showing Strong Apparent Performance Relative To GLP-1, Appears To Be Working With Semaglutide Both With And Without SNAC Technology

Author: Benzinga Newsdesk | July 17, 2024 10:37am

- Reuters 

Posted In: LEXX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist